Related Experiment Videos
[Aortic valve replacement with stentless porcine aortic valve]
K Nakano1, K Eishi, J Kobayashi
1National Cardiovascular Center, Osaka.
Journal of Cardiology
|January 1, 1997
Summary
The Toronto stentless porcine valve (TSPV) shows excellent hemodynamic performance in aortic valve replacement. This bioprosthesis may be widely indicated, though long-term durability requires further study.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
Context:
- Aortic valve replacement is a critical procedure for patients with severe aortic valve disease.
- Stentless bioprostheses aim to improve hemodynamic function and durability compared to stented valves.
- The Toronto stentless porcine valve (TSPV) is a novel bioprosthesis designed for optimal blood flow.
Purpose:
- To evaluate the early hemodynamic performance and safety of the Toronto stentless porcine valve (TSPV) in patients undergoing aortic valve replacement.
- To assess the feasibility of TSPV implantation in a patient cohort with specific indications like advanced age and connective tissue disease.
Summary:
- Seven patients underwent aortic valve replacement with TSPV, primarily due to advanced age or connective tissue disease.
- One patient required reoperation for prosthetic valve endocarditis; no other valve-related complications were observed.
- Early echocardiographic results demonstrated no aortic regurgitation and a transprosthetic gradient of 15.1 +/- 5.0 mmHg, indicating excellent hemodynamic characteristics.
- Technical expertise is necessary for successful TSPV implantation.
Impact:
- The TSPV exhibits excellent early hemodynamic performance, suggesting potential as a superior bioprosthesis.
- Further long-term follow-up is necessary to establish the durability of the TSPV.
- The study anticipates broader clinical adoption of the TSPV in aortic valve replacement procedures.